# A&D HOLON Holdings Company, Limited: business model and financials

> Latest period: FY ending Mar 2026, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第49期(2025/04/01－2026/03/31) (S100YHHI)
> Page: https://vizora.meequs.com/en/company/a-and-d-holon-holdings
> Retrieved: 2026-09-30T22:57:19.612Z

## Company

A&D HOLON Holdings, founded in 1977, is a company in Semiconductor Equipment listed on TSE Prime. It has 2,480 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | A&D HOLON Holdings Company, Limited |
| Ticker | 7745 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/7745.T) |
| Listing | TSE Prime |
| Head office | 東京都豊島区東池袋三丁目23番14号(同所は登記上の本店所在地で実際の業務は「最寄りの連絡場所」で 行っております。) |
| Representative (per filing) | 代表取締役執行役員社長 森島 泰信 |
| Founded | May 1977 |
| Share capital | ¥6.39B |
| Employees (consolidated) | 2,480 |
| Fiscal year end | March |
| Website | andholon.com (https://andholon.com/) |
| Corporate number | 5013301001710 |
| EDINET | E02344 |
| Industries (Vizora) | Semiconductor Equipment, Robots & Factory Automation, Medical Devices |

> Profile source: annual securities report (S100YHHI, filed 2026-06-23). As of filing

## Five-axis industry profile

Primary industry: Robots & Factory Automation (2026-03-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 56.1 | 33 |
| Profitability | 63.2 | 34 |
| Cash conversion | 17.2 | 32 |
| Efficiency | 92.9 | 35 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- About 23% of A&D HOLON Holdings's sales come from Measurement/Weighing Instruments Businesses, with Medical/Healthcare Instruments Businesses and Japan making up much of the rest.
- Out of every ¥100 of sales, about ¥13 is left as operating profit.
- Revenue changed +3.3% from the prior year, operating profit +4.5%.

## Company structure

- Segment revenue mix: Measurement/Weighing Instruments Businesses 22.8%、Medical/Healthcare Instruments Businesses 19.2%、Japan 14.6%、America 8.0%、Semiconductor-related business 8.0%
- Revenue → net income: ¥69326000000 → ¥5947000000
- Net income → operating cash flow: ¥5947000000 → ¥6469000000（difference ¥522000000）
- Main uses of operating cash flow: CapEx ¥3622000000 / dividends ¥1248000000 / buybacks ¥0
- Change in cash: ¥361000000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥69.3B |  |
| Operating income | ¥9.21B | Margin 13.3% |
| Net income | ¥5.92B | Margin 8.5% |
| Free cash flow | ¥2.85B |  |
| Largest business | Measurement/Weighing Instruments Businesses | of segment revenue 22.8% |
| Employees (consolidated) | 2,480 |  |
| EPS | ¥81.61 |  |
| Diluted EPS | ¥81.53 |  |
| Book value per share | ¥974.61 |  |
| Equity ratio | 65.7% |  |
| Shares outstanding | 27,845,000 |  |
| Treasury shares | 120,100 |  |
| Shareholders | 6,259 |  |
| Cash ratio | 18.1% | Cash ÷ revenue 19.6% |
| Vs. industry median margin | +1.5 pp | Robots & Factory Automation |
| ROE | 13.0% | Derived from disclosed figures |
| ROA | 8.2% | Derived from disclosed figures |

## What changed in 5 years

| Metric | FY ending Mar 2021 | FY ending Mar 2026 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥48424000000 | ¥69326000000 | +43.2% |
| Operating income | ¥4404000000 | ¥9209000000 | +109.1% |
| Operating margin | 9.1% | 13.3% | +4.2 pp |
| Employees | 2,544 people | 2,480 people | -2.5% |
| Cash and equivalents | ¥12129000000 | ¥13618000000 | +12.3% |

### Change in segment revenue mix

Span: FY ending Mar 2021 → FY ending Mar 2026. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

| Flow | Revenue share |
| --- | ---: |
| 日本 → 日本 | 14.6% |
| 日本 → 事業再編・廃止 | 5.4% |
| 米州 → 米州 | 3.3% |
| 欧州 → 欧州 | 0.4% |
| 欧州 → 事業再編・廃止 | 0.4% |
| アジア・オセアニア → アジア・オセアニア | 3.4% |
| 計測・計量機器事業 → 計測・計量機器事業 | 22.8% |
| 計測・計量機器事業 → 事業再編・廃止 | 4.8% |
| 日本 → 日本 | 3.1% |
| 日本 → 事業再編・廃止 | 3.5% |
| 米州 → 米州 | 7.8% |
| 欧州 → 欧州 | 7.6% |
| アジア・オセアニア → アジア・オセアニア | 0.4% |
| 医療・健康機器事業 → 医療・健康機器事業 | 19.2% |
| 医療・健康機器事業 → 事業再編・廃止 | 3.2% |
| 新設・再編 → 日本、半導体関連 | 8.0% |
| 新設・再編 → 半導体関連事業 | 8.0% |
| 新設・再編 → 米州 | 0.3% |
| 新設・再編 → アジア・オセアニア | 0.7% |
| 新設・再編 → 米州 | 0.2% |
| 新設・再編 → 欧州 | 0.1% |
| 新設・再編 → アジア・オセアニア | 0.0% |
| 新設・再編 → アジア・オセアニア、半導体関連事業 | 0.0% |

Segment revenue source references: 23 (derived)

## Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: latest revenue. CAGR requires at least two comparable years.

| Segment | CAGR span | Revenue CAGR | Latest revenue | Operating margin | Source refs |
| --- | ---: | ---: | ---: | ---: | ---: |
| Measurement/Weighing Instruments Businesses | 5 years | +3.4% | ¥31545000000 | 10.7% | 2 |
| Medical/Healthcare Instruments Businesses | 5 years | +4.1% | ¥26667000000 | 15.0% | 2 |
| Japan | 5 years | +0.9% | ¥20241000000 | 15.1% | 2 |
| America | 5 years | +8.0% | ¥11129000000 | 1.5% | 2 |
| Semiconductor-related business | 4 years | +21.6% | ¥11114000000 | 32.6% | 2 |
| Japan, Semiconductor-related business | 4 years | +21.6% | ¥11099000000 | 32.6% | 2 |
| Europe | 5 years | +7.6% | ¥10598000000 | 4.3% | 2 |
| Asia and Oceania | 5 years | +11.3% | ¥5696000000 | 11.1% | 2 |
| America | 5 years | +9.3% | ¥4989000000 | -6.9% | 2 |
| Japan | 5 years | -7.6% | ¥4348000000 | 74.6% | 2 |
| Europe | 5 years | -5.1% | ¥618000000 | 6.6% | 2 |
| Asia and Oceania | 5 years | +9.3% | ¥590000000 | 23.9% | 2 |
| Asia and Oceania, Semiconductor-related business | — | — | ¥15000000 | 46.7% | 2 |

## Income statement（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 69,326 | 100.0% | S100YHHI |
| Cost of revenue | 37,875 | 54.6% | S100YHHI |
| Gross profit | 31,451 | 45.4% | S100YHHI |
| SG&A | 22,241 | 32.1% | S100YHHI |
| Operating income | 9,209 | 13.3% | S100YHHI |
| Ordinary income | 9,470 | 13.7% | S100YHHI |
| Pretax income | 8,669 | 12.5% | S100YHHI |
| Income tax | 2,722 | 3.9% | S100YHHI |
| Net income | 5,947 | 8.6% | S100YHHI |
| Net income attributable to owners | 5,923 | 8.5% | S100YHHI |

## Per ¥100 of revenue（FY ending Mar 2026）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 55 |
| SG&A | 32 |
| Operating income | 13 |
| (Ref.) Net income | 9 |

### Margin funnel

Gross margin 45.4% → Operating margin 13.3% → Net margin 8.5%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Revenue and profit up
Revenue growth: +3.3%; Core profit growth: +4.5%
Growth quality: margin-expansion
Operating leverage (core profit growth ÷ revenue growth): 1.34×
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Mar 2025 → FY ending Mar 2026、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 67,083 | 69,326 | 2,243 | +3.3% |
| Gross profit | 30,203 | 31,451 | 1,248 | +4.1% |
| Operating income | 8,813 | 9,209 | 396 | +4.5% |
| Net income attributable to owners | 6,468 | 5,923 | -545 | -8.4% |
| Operating cash flow | 6,578 | 6,469 | -109 | -1.7% |
| Free cash flow | 4,560 | 2,847 | -1,713 | -37.6% |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Mar 2020 | 49,197 | 3,700 | 7.5% | 1,576 | 4,309 | 3,229 | S100LL8G |
| FY ending Mar 2021 | 48,424 | 4,404 | 9.1% | 3,339 | 5,194 | 3,042 | S100OHD5 |
| FY ending Mar 2022 | 51,736 | 5,496 | 10.6% | 3,573 | 1,782 | -782 | S100RAOL |
| FY ending Mar 2023 | 59,028 | 7,475 | 12.7% | 5,524 | 4,096 | 2,572 | S100TTWW |
| FY ending Mar 2024 | 61,955 | 7,955 | 12.8% | 5,299 | 7,201 | 5,102 | S100W7MR |
| FY ending Mar 2025 | 67,083 | 8,813 | 13.1% | 6,468 | 6,578 | 4,560 | S100YHHI |
| FY ending Mar 2026 | 69,326 | 9,209 | 13.3% | 5,923 | 6,469 | 2,847 | S100YHHI |

## People and productivity（FY ending Mar 2026, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥28M |
| Operating income per employee (consolidated) | ¥3.7M |
| Net income per employee (consolidated) | ¥2.4M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 2,591 | 2,495 | 2,471 | 2,438 | 2,480 |
| Average salary (parent company) | ¥7.4M | — | — | — | — |
| Average age (parent company) | 42.3 years | — | — | — | — |
| Average tenure (parent company) | 15.5 years | — | — | — | — |

Year over year: Employees (consolidated) +1.7% · Revenue (consolidated) +3.3%

## Segments（FY ending Mar 2026, consolidated, J-GAAP、JPY mn）

| Segment | Revenue | Share | Op. income | Op. margin |
| --- | ---: | ---: | ---: | ---: |
| Japan, Semiconductor-related business | 11,099 | 8.0% | 3,620 | 32.6% |
| Semiconductor-related business | 11,114 | 8.0% | 3,628 | 32.6% |
| Japan | 20,241 | 14.6% | 3,060 | 15.1% |
| America | 4,989 | 3.6% | -345 | -6.9% |
| Europe | 618 | 0.4% | 41 | 6.6% |
| Asia and Oceania | 5,696 | 4.1% | 630 | 11.1% |
| Measurement/Weighing Instruments Businesses | 31,545 | 22.8% | 3,387 | 10.7% |
| Japan | 4,348 | 3.1% | 3,244 | 74.6% |
| America | 11,129 | 8.0% | 168 | 1.5% |
| Europe | 10,598 | 7.6% | 454 | 4.3% |
| Asia and Oceania | 590 | 0.4% | 141 | 23.9% |
| Medical/Healthcare Instruments Businesses | 26,667 | 19.2% | 4,009 | 15.0% |
| Asia and Oceania, Semiconductor-related business | 15 | 0.0% | 7 | 46.7% |

### segmentMix — Revenue and profit mix

Calculated from disclosed figures (DERIVED). Shares use total segment revenue and total positive segment profit respectively. Difference = profit share − revenue share (pt). Inter-segment sales may prevent reconciliation to company revenue.

| Segment | Revenue share | Profit share | Difference (pt) | Margin |
| --- | ---: | ---: | ---: | ---: |
| Japan, Semiconductor-related business | 8.0% | 16.2% | 8.2 | 32.6% |
| Semiconductor-related business | 8.0% | 16.2% | 8.2 | 32.6% |
| Japan | 14.6% | 13.7% | -0.9 | 15.1% |
| America | 3.6% | — | — | -6.9% |
| Europe | 0.4% | 0.2% | -0.3 | 6.6% |
| Asia and Oceania | 4.1% | 2.8% | -1.3 | 11.1% |
| Measurement/Weighing Instruments Businesses | 22.8% | 15.1% | -7.6 | 10.7% |
| Japan | 3.1% | 14.5% | 11.4 | 74.6% |
| America | 8.0% | 0.8% | -7.3 | 1.5% |
| Europe | 7.6% | 2.0% | -5.6 | 4.3% |
| Asia and Oceania | 0.4% | 0.6% | 0.2 | 23.9% |
| Medical/Healthcare Instruments Businesses | 19.2% | 17.9% | -1.3 | 15.0% |
| Asia and Oceania, Semiconductor-related business | 0.0% | 0.0% | 0.0 | 46.7% |

Loss-making segment (excluded from profit shares): America -345 JPY mn

Segment → industry: Japan, Semiconductor-related business → Semiconductor Equipment / Semiconductor-related business → Semiconductor Equipment / Japan → Robots & Factory Automation / America → Robots & Factory Automation / Europe → Robots & Factory Automation / Asia and Oceania → Robots & Factory Automation / Measurement/Weighing Instruments Businesses → Robots & Factory Automation / Japan → Medical Devices / America → Medical Devices / Europe → Medical Devices / Asia and Oceania → Medical Devices / Medical/Healthcare Instruments Businesses → Medical Devices / Asia and Oceania, Semiconductor-related business → Semiconductor Equipment

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 6,469 | 9.3% | S100YHHI |
| Capital expenditure | 3,622 | 5.2% | S100YHHI |
| Free cash flow | 2,847 | 4.1% | 算出 |
| Investing cash flow | -3,792 | -5.5% | S100YHHI |
| Financing cash flow | -2,909 | -4.2% | S100YHHI |
| Dividends paid | 1,248 | 1.8% | S100YHHI |
| Share buyback | 0 | 0.0% | S100YHHI |
| Change in cash | 361 | 0.5% | S100YHHI |
| Cash and equivalents | 13,618 | 19.6% | S100YHHI |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 11,012 | 14,315 | 14,016 | 13,257 | 13,618 | S100TTWW, S100W7MR, S100YHHI |
| Total assets | 59,239 | 69,418 | 71,986 | 69,005 | 75,277 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Net assets | 27,041 | 32,574 | 37,762 | 42,797 | 49,577 | S100TTWW, S100W7MR, S100YHHI |
| Share capital | 6,388 | 6,388 | 6,388 | 6,388 | 6,388 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Property, plant and equipment | 11,382 | 12,267 | 12,918 | 12,875 | 14,606 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Intangible assets excluding goodwill | 1,476 | 1,468 | 1,345 | 1,338 | 1,543 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Goodwill | 123 | 35 | 7 | 3 | 146 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Investment securities | 168 | 175 | 204 | 315 | 357 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Current assets | 43,946 | 52,660 | 54,368 | 51,668 | 55,292 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Current liabilities | 26,202 | 31,202 | 29,896 | 22,780 | 23,149 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Trade payables | 5,141 | 4,971 | 5,265 | 3,971 | 3,500 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Short-term borrowings | 12,029 | 14,731 | 13,433 | 10,811 | 10,447 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Long-term borrowings | 3,813 | 3,292 | 2,097 | 1,267 | 174 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Bonds | 500 | — | — | — | — | S100RAOL |
| Interest-bearing debt | 16,342 | — | — | — | — | 算出 |
| Total liabilities | 32,198 | 36,843 | 34,223 | 26,207 | 25,700 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Non-controlling interests | 2,885 | 72 | 89 | 86 | 96 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Equity attributable to owners of parent | 26,125 | 33,677 | 38,017 | 43,119 | 47,809 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Retained earnings | 14,367 | 19,142 | 23,471 | 28,831 | 33,507 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |
| Treasury stock | -1,044 | -172 | -162 | -446 | -432 | S100RAOL, S100TTWW, S100W7MR, S100YHHI |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 18% | S100YHHI |
| Property, plant and equipment | 19% | S100YHHI |
| Intangibles and goodwill | 2% | S100YHHI |
| Investment securities | 1% | S100YHHI |
| Other assets | 60% | S100YHHI |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Trade payables | 5% | S100YHHI |
| Other liabilities | 29% | S100YHHI |
| Equity | 66% | S100YHHI |

### Balance sheet history

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 59,239 | 69,418 | 71,986 | 69,005 | 75,277 |
| Equity | 27,041 | 32,574 | 37,762 | 42,797 | 49,577 |
| Interest-bearing debt | 16,342 | — | — | — | — |
| Cash | 11,012 | 14,315 | 14,016 | 13,257 | 13,618 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 21.1% | S100YHHI |
| Fixed assets ÷ total assets | 19.4% | S100YHHI |
| Goodwill ÷ parent equity | 0.3% | S100YHHI |

Goodwill over 4 years: 123 → 146 JPY; total investing cash flow: -11,563 JPY. This does not imply causation.

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 18.1% |
| Cash ÷ revenue | 19.6% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | 70.2% |
| Cash vs. profit gap | 546 JPY mn (of net income 9.2%) |
| Shareholder returns / net income | 21.1% |
| Shareholder returns / FCF | 43.8% |
| Shareholder payments — dividends / net income | 21.1% |
| Shareholder payments — dividends / FCF | 43.8% |
| CapEx intensity (capex ÷ revenue) | 5.2% |
| Investing CF relative to operating CF | 58.6% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2022 | 6.9% | 0.87× | 6.0% | 2.27× | 13.7% | S100RAOL |
| 2023 | 9.4% | 0.92× | 8.6% | 2.15× | 18.5% | S100TTWW |
| 2024 | 8.6% | 0.88× | 7.5% | 1.97× | 14.8% | S100W7MR |
| 2025 | 9.6% | 0.95× | 9.2% | 1.74× | 15.9% | S100YHHI |
| 2026 | 8.5% | 0.96× | 8.2% | 1.59× | 13.0% | S100YHHI |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 日本マスタートラスト信託銀行㈱（信託口） | Major shareholder | 14.4% | 2026-03-31 |
| INTERTRUST TRUSTEES(CAYMAN) LIMITED SOLELY IN ITS CAPACITY AS TRUSTEE OF JAPAN－UP（常任代理人 ㈱みずほ銀行決済営業部） | Major shareholder | 7.8% | 2026-03-31 |
| NORTHERN TRUST CO. (AVFC) RE IEDP AIF CLIENTS NON TREATY ACCOUNT（常任代理人 香港上海銀行東京支店 カストディ業務部） | Major shareholder | 4.1% | 2026-03-31 |
| ㈱日本カストディ銀行（信託口） | Major shareholder | 4.0% | 2026-03-31 |
| INTERTRUST TRUSTEES CAYMAN LIMITED AS TRUSTEE OF JAPAN－UP UNIT TRUST（常任代理人 立花証券㈱） | Major shareholder | 2.5% | 2026-03-31 |
| Ａ＆Ｄホロンホールディングス従業員持株会 | Major shareholder | 2.5% | 2026-03-31 |
| STATE STREET BANK AND TRUST COMPANY 505001（常任代理人 ㈱みずほ銀行決済営業部） | Major shareholder | 2.4% | 2026-03-31 |
| ㈱埼玉りそな銀行 | Major shareholder | 2.2% | 2026-03-31 |
| MSIP CLIENT SECURITIES（常任代理人 モルガン・スタンレーMUFG証券㈱） | Major shareholder | 2.1% | 2026-03-31 |
| THE BANK OF NEW YORK MELLON 140044（常任代理人 ㈱みずほ銀行決済営業部） | Major shareholder | 2.0% | 2026-03-31 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第49期(2025/04/01－2026/03/31) | S100YHHI | 2026-06-23 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHHI,, |
| 有価証券報告書－第48期(2024/04/01－2025/03/31) | S100W7MR | 2025-06-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100W7MR,, |
| 有価証券報告書－第47期(2023/04/01－2024/03/31) | S100TTWW | 2024-06-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100TTWW,, |
| 有価証券報告書－第46期(2022/04/01－2023/03/31) | S100RAOL | 2023-06-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100RAOL,, |
| 有価証券報告書－第45期(令和3年4月1日－令和4年3月31日) | S100OHD5 | 2022-06-27 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100OHD5,, |
| 有価証券報告書－第44期(令和2年4月1日－令和3年3月31日) | S100LL8G | 2021-06-25 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100LL8G,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).